Can you take Ozempic or Mounjaro when pregnant?
No. Ozempic, Wegovy, Mounjaro, Saxenda and Rybelsus are all not recommended during pregnancy, and every manufacturer advises discontinuing if you become pregnant. If you are planning a pregnancy, the guidance is to stop semaglutide at least two months beforehand and tirzepatide at least one month beforehand, because of how long these drugs persist in the body. Animal studies showed harm to the developing fetus, and there is not enough human data to establish safety. If you discover you are pregnant while taking one, contact your prescriber promptly — but do not panic, and do not assume the worst.
What the manufacturers and regulators actually say
This is not a grey area. Every GLP-1 licensed in Ireland carries the same position.
- Ozempic and Wegovy (semaglutide). Not recommended in pregnancy. Discontinue at least two months before a planned pregnancy.
- Rybelsus (oral semaglutide). Same position, same two-month advice.
- Mounjaro (tirzepatide). Not recommended in pregnancy. Discontinue at least one month before a planned pregnancy.
- Saxenda (liraglutide). Not recommended in pregnancy. Discontinue if pregnancy occurs.
The differing washout periods are about half-life rather than differing degrees of concern. Semaglutide persists roughly a week per half-life and takes around five weeks to clear substantially, so two months is a margin of safety. Liraglutide is a daily injection and clears within days.
Why they are not recommended
Two reasons, and the second is as important as the first.
In animal reproduction studies, GLP-1 receptor agonists produced adverse effects on the developing fetus, including reduced growth and skeletal abnormalities, at exposures relevant to human dosing. Animal findings do not automatically translate to people, but they are enough for a regulator to advise against use where there is no compelling need.
The second reason is more fundamental: there is not enough human data. Pregnant women are excluded from these trials, as they are from most drug trials, so the safety database is thin. Absence of evidence of harm is not evidence of safety, and no regulator will treat it as such.
There is also a straightforward physiological argument. Pregnancy is not a time for intentional weight loss or for suppressed nutritional intake, and these medicines do both.
What if you are already pregnant and taking one
Contact your GP, obstetrician or prescriber and tell them. Do not simply stop and say nothing, particularly if you have type 2 diabetes, because untreated high blood sugar in pregnancy carries its own significant risks and your treatment will need replacing rather than just removing.
It is also worth saying clearly: this is not a catastrophe and it is more common than you think. Many pregnancies have occurred on GLP-1 treatment, and the available human data has not shown the pattern of harm the animal studies raised. It needs prompt medical attention, not despair. Your maternity team will want to know, and they will have seen it before.
The contraception problem nobody mentions
This matters more than its coverage suggests, and it is a large part of why unplanned pregnancies on these medicines have become a talking point.
Tirzepatide can reduce the effectiveness of oral contraceptives. It slows gastric emptying, which affects absorption of the pill. The manufacturer advises that people using an oral contraceptive should switch to a non-oral method, or add a barrier method, for four weeks after starting Mounjaro and for four weeks after each dose increase.
Semaglutide has not shown a clinically relevant effect on oral contraceptives in the same way. But there is a second, more general point that applies to all of these medicines: weight loss can restore ovulation in people with PCOS or obesity-related infertility who had assumed they could not conceive easily. Fertility can return before anyone thinks to discuss it.
If you are planning a pregnancy
Have the conversation with your prescriber before you stop, not after. There are three things worth working through.
- Timing. Two months for semaglutide, one for tirzepatide, from the manufacturers.
- What replaces it. Particularly important with type 2 diabetes, where glycaemic control before and during pregnancy matters a great deal.
- Regain. Weight typically returns after stopping, and it is better to plan for that than to be surprised by it.
Weight loss before conception has genuine benefits, reducing the risk of gestational diabetes, pre-eclampsia and complications at delivery. So achieving it and then stopping in good time is a reasonable strategy. It just needs to be a plan rather than an accident.
Where to get proper advice in Ireland
Your GP is the first stop. If you have type 2 diabetes and are planning a pregnancy, ask about pre-conception counselling, which is available through the maternity services and is genuinely worth attending.
For anything urgent, contact your maternity unit directly. The HSE also runs pregnancy information services, and the Irish Medicines Information Service can answer specific questions about medicines in pregnancy through your pharmacist or doctor.
Nothing on this page replaces that conversation. It exists so that you walk into it knowing what the guidance says.
Ozempic and pregnancy: common questions
No. Ozempic is not recommended during pregnancy and the manufacturer advises discontinuing if you become pregnant. Animal studies showed adverse effects on fetal development and there is insufficient human data to establish safety.
At least two months before a planned pregnancy, according to the manufacturer. Semaglutide has a half-life of about a week and takes roughly five weeks to clear substantially, so two months provides a margin of safety.
At least one month before a planned pregnancy. Tirzepatide has a shorter half-life than semaglutide at around five days, which is why the recommended washout is shorter.
Contact your GP, obstetrician or prescriber promptly. Do not simply stop without telling anyone, particularly if you have type 2 diabetes, because your treatment will need replacing. The available human data has not shown the pattern of harm the animal studies raised.
Yes. Tirzepatide can reduce the effectiveness of oral contraceptives by slowing gastric emptying. The manufacturer advises switching to a non-oral method or adding a barrier method for four weeks after starting and for four weeks after each dose increase.
Indirectly, yes. Weight loss can restore ovulation in people with PCOS or obesity-related infertility, so conception can become possible for people who assumed it was unlikely. This is a common reason unplanned pregnancies occur on these medicines.